Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Maxcyte Inc (MXCT)

Maxcyte Inc (MXCT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 627,355
  • Shares Outstanding, K 102,009
  • Annual Sales, $ 33,890 K
  • Annual Income, $ -19,080 K
  • 60-Month Beta 0.55
  • Price/Sales 18.42
  • Price/Cash Flow N/A
  • Price/Book 2.45
Trade MXCT with:

Options Overview Details

View History
  • Implied Volatility 86.54% ( +21.99%)
  • Historical Volatility 73.15%
  • IV Percentile 57%
  • IV Rank 31.62%
  • IV High 228.12% on 08/08/22
  • IV Low 21.07% on 08/15/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 774
  • Open Int (30-Day) 677

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.89 +4.41%
on 11/22/22
7.41 -17.00%
on 11/11/22
-0.86 (-12.27%)
since 10/28/22
3-Month
5.01 +22.75%
on 09/01/22
7.50 -18.00%
on 10/04/22
+0.69 (+12.64%)
since 08/26/22
52-Week
3.36 +83.04%
on 06/16/22
11.56 -46.80%
on 12/08/21
-3.58 (-36.79%)
since 11/26/21

Most Recent Stories

More News
MaxCyte, Inc. (MXCT) Reports Q3 Loss, Tops Revenue Estimates

MaxCyte, Inc. (MXCT) delivered earnings and revenue surprises of 33.33% and 2.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MXCT : 6.15 (+0.49%)
CDMO : 14.99 (+1.90%)
Vanda Pharmaceuticals (VNDA) Lags Q3 Earnings and Revenue Estimates

Vanda (VNDA) delivered earnings and revenue surprises of -40% and 8%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VNDA : 10.29 (-1.34%)
MXCT : 6.15 (+0.49%)
MaxCyte, Inc. (MXCT) Moves 9.3% Higher: Will This Strength Last?

MaxCyte, Inc. (MXCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

MXCT : 6.15 (+0.49%)
AVEO : 14.86 (-0.07%)
MaxCyte, Inc. (MXCT) Q2 2022 Earnings Call Transcript

MXCT earnings call for the period ending June 30, 2022.

MXCT : 6.15 (+0.49%)
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Tops Revenue Estimates

MaxCyte, Inc. (MXCT) delivered earnings and revenue surprises of 0% and 6.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MXCT : 6.15 (+0.49%)
ANGN : 0.8785 (-2.39%)
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md.,...

MXCT : 6.15 (+0.49%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 530.000 (+1.92%)
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of 55.43% and 714.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ARCT : 16.09 (-2.37%)
MXCT : 6.15 (+0.49%)
Akoya Biosciences (AKYA) Reports Q2 Loss, Tops Revenue Estimates

Akoya (AKYA) delivered earnings and revenue surprises of -38.24% and 5.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AKYA : 12.36 (-3.74%)
MXCT : 6.15 (+0.49%)
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022

GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 6.15 (+0.49%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 530.000 (+1.92%)
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GAITHERSBURG, Md., May 13, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 6.15 (+0.49%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 530.000 (+1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MaxCyte Inc. is a provider of cell-engineering enabling technology and is responsible cell-based therapies. MaxCyte Inc. is headquartered in Gaithersburg, Maryland.

See More

Key Turning Points

3rd Resistance Point 6.80
2nd Resistance Point 6.62
1st Resistance Point 6.38
Last Price 6.15
1st Support Level 5.96
2nd Support Level 5.78
3rd Support Level 5.54

See More

52-Week High 11.56
Fibonacci 61.8% 8.43
Fibonacci 50% 7.46
Fibonacci 38.2% 6.49
Last Price 6.15
52-Week Low 3.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar